MedTrace Logo

Hemp-Derived Botanical Dietary Supplementation During Recovery From Brain Injury

NCT03826368 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-04-15

No results posted yet for this study

Summary

The objective of the proposed research is to evaluate adult subjects currently taking phytocannabinoid Hemp-derived botanical supplements (HDS) during recovery from traumatic brain injury. This study seeks to answer whether subjects taking HDS formulations experience relief from self-reported symptoms or improved subjective well-being, sleep quality, cognitive benefits, side effects and/or quantifiable changes in brain state neuronal activity or stress biomarkers. We seek to answer whether regular users (once/week to multiple uses/day) of HDS experience signs of dependence, addiction or physiological withdrawal. To accomplish this we will use survey questions, quantitative EEG, cognitive testing and salivary biomarkers to determine the effectiveness of self-initiated HDS administration. In addition, we are interested in whether our objective measures allow us to understand why some people are responders to HDS health benefits while others are not.

Conditions

Interventions

DIETARY_SUPPLEMENT

Hemp-derived botanical dietary supplement

Subjects currently taking phytocannabinoid Hemp-derived botanical dietary supplements during recovery from brain injury.

Sponsors & Collaborators

  • Real Time Diagnostics Ventures INC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-13
Primary Completion
2020-04-13
Completion
2020-04-13

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826368 on ClinicalTrials.gov